AGIOS PHARMACEUTICALS, INC. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 23,572 | 7,131 | 117,567 | |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 82.22 | 2,966 | 243,865 | 0 | 3 K to 0 (-100.00 %) |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 81.40 | 11,369 | 925,437 | 2,966 | 14.3 K to 3 K (-79.31 %) |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.35 | 9,237 | 742,193 | 14,335 | 23.6 K to 14.3 K (-39.19 %) |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 23,572 | 7,131 | 23,572 | 0 to 23.6 K |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 52.29 | 2,150 | 112,424 | 12,850 | |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 75.00 | 2,150 | 161,250 | 0 | 2.2 K to 0 (-100.00 %) |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 52.29 | 2,150 | 112,424 | 2,150 | 0 to 2.2 K |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 20 | 6 | 141,139 | |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 20 | 1,600 | 0 | 20 to 0 (-100.00 %) |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 20 | 6 | 20 | 0 to 20 |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 25,000 | 994,000 | 75,000 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.83 | 25,000 | 1,870,750 | 0 | 25 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 25,000 | 994,000 | 25,000 | 0 to 25 K |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,533 | 4,094 | 141,159 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 32,875 | 9,945 | 5,962 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 13,533 | 1,082,775 | 0 | 13.5 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,533 | 4,094 | 13,533 | 0 to 13.5 K |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 32,875 | 2,630,329 | 0 | 32.9 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 32,875 | 9,945 | 32,875 | 0 to 32.9 K |
| Jan 23 2018 | AGIO | AGIOS PHARMACEUTIC ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 67.00 | 851,154 | 57,027,318 | 1,374,599 | 523.4 K to 1.4 M (+162.61 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 53,000 | 16,033 | 154,692 | |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 74.80 | 6,597 | 493,456 | 0 | 6.6 K to 0 (-100.00 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 74.11 | 10,914 | 808,837 | 6,597 | 17.5 K to 6.6 K (-62.33 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 73.02 | 22,304 | 1,628,638 | 17,511 | 39.8 K to 17.5 K (-56.02 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 71.77 | 13,185 | 946,287 | 39,815 | 53 K to 39.8 K (-24.88 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 53,000 | 16,033 | 53,000 | 0 to 53 K |
| Jan 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 3,000 | 1,403 | 1,867 | |
| Jan 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 3,000 | 195,000 | 53,059 | 56.1 K to 53.1 K (-5.35 %) |
| Jan 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 3,000 | 1,403 | 56,059 | 53.1 K to 56.1 K (+5.65 %) |